| Andrea Pasminski, | |
|
2430 Esplanade Dr Ste B, Algonquin, IL 60102-5500 | |
| (844) 307-7546 | |
| Not Available |
| Full Name | Andrea Pasminski |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 3 Years |
| Location | 2430 Esplanade Dr Ste B, Algonquin, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396415238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Specialists Of Illinois, Ltd | 7517288236 | 6 |
News Archive
"[T]he impact of [a decision by the Supreme Court in India to disallow a new patent for an updated version of Novartis' cancer drug Glivec] will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets," Thomas Bollyky, senior fellow for global health, economics, and development at the Council on Foreign Relations and an adjunct professor of law at Georgetown University, writes in an Atlantic opinion piece.
NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela's chairman, president and chief executive officer, has been invited to participate in Retina International's annual Scientific & Medical Advisory Board meeting being held in Fort Lauderdale, Florida on May 3, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Pasminski, 2430 Esplanade Dr Ste B, Algonquin, IL 60102-5500 Ph: (847) 917-5124 | Andrea Pasminski, 2430 Esplanade Dr Ste B, Algonquin, IL 60102-5500 Ph: (844) 307-7546 |
News Archive
"[T]he impact of [a decision by the Supreme Court in India to disallow a new patent for an updated version of Novartis' cancer drug Glivec] will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets," Thomas Bollyky, senior fellow for global health, economics, and development at the Council on Foreign Relations and an adjunct professor of law at Georgetown University, writes in an Atlantic opinion piece.
NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela's chairman, president and chief executive officer, has been invited to participate in Retina International's annual Scientific & Medical Advisory Board meeting being held in Fort Lauderdale, Florida on May 3, 2010.
› Verified 3 days ago
Sydney Nicole Sabino, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 650 S Randall Rd, Algonquin, IL 60102 Phone: 815-398-9491 | |
Johnathan Salvi, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1106 N Main St, Algonquin, IL 60102 Phone: 224-333-0928 Fax: 224-209-8685 | |
Chelsea Lauren Thomas, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 650 S Randall Rd, Algonquin, IL 60102 Phone: 815-398-9491 Fax: 815-381-7498 | |
Kelley Zych, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1340 Ryan Pkwy, Algonquin, IL 60102 Phone: 815-276-0150 Fax: 877-461-6742 | |
Wajiha Imran Masood, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1465 Commerce Dr, Algonquin, IL 60102 Phone: 847-802-7090 Fax: 847-802-7095 | |
Don A Larson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 650 S Randall Rd, Algonquin, IL 60102 Phone: 815-398-9491 Fax: 815-381-7498 | |
Amanda L Frakes, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 650 S Randall Rd, Algonquin, IL 60102 Phone: 815-398-9491 Fax: 815-381-7498 |